Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
event decrease » cement decreases (Expand Search), levels decreased (Expand Search)
point decrease » point increase (Expand Search)
decrease risk » increased risk (Expand Search), increases risk (Expand Search), disease risk (Expand Search)
Showing 121 - 140 results of 19,881 for search '(( significant decrease risk ) OR ( significant ((event decrease) OR (point decrease)) ))', query time: 1.35s Refine Results
  1. 121
    Differences in population distribution between MediScope® and the actual population in Japan.

    Differences in population distribution between MediScope® and the actual population in Japan. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 122
    Switching patterns of ICS/LABA.

    Switching patterns of ICS/LABA. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 123
    Factors associated with exacerbations.

    Factors associated with exacerbations. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 124
    Definition of each exacerbation.

    Definition of each exacerbation. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  5. 125
    Definitions of treatment step classification.

    Definitions of treatment step classification. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  6. 126
    Sensitivity analyses of breakthrough exacerbations.

    Sensitivity analyses of breakthrough exacerbations. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 127
    Baseline characteristics of patients.

    Baseline characteristics of patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 128
    Data for primary and sensitivity analysis.

    Data for primary and sensitivity analysis. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 129
    Study design.

    Study design. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 130
    Odds ratios for each case period compared with the control period.

    Odds ratios for each case period compared with the control period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 131
    Sensitivity analysis of the group who had an exacerbation before the index date.

    Sensitivity analysis of the group who had an exacerbation before the index date. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 132
    Initial post-switch visits and SABA prescriptions in each period.

    Initial post-switch visits and SABA prescriptions in each period. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 133
    Flow of eligible patients.

    Flow of eligible patients. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 134
    ICS/LABA before and after switch.

    ICS/LABA before and after switch. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 135
    Diseases excluded from the analysis.

    Diseases excluded from the analysis. by Rieko Kondo (10010647)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 136
    Forest Plot of the incidence of serious adverse events in MSCs therapy group and control group.

    Forest Plot of the incidence of serious adverse events in MSCs therapy group and control group. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 137
    L’Abbé plot for the incidence of adverse events in the MSCs therapy group and control group.

    L’Abbé plot for the incidence of adverse events in the MSCs therapy group and control group. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 138
    EGFR/ERK signaling activity decreases throughout LEC elimination with endocytic activity dependency.

    EGFR/ERK signaling activity decreases throughout LEC elimination with endocytic activity dependency. by Kevin Yuswan (19845885)

    Published 2024
    Save to List
    Saved in:
  19. 139
    Risk of bias assessment in the non-RCTs of Wang, 2013 –ROBINS-I tool.

    Risk of bias assessment in the non-RCTs of Wang, 2013 –ROBINS-I tool. by Luz Estella Mesa (8339283)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 140
    Georeferences of <i>Mansonia</i> spp. monitoring points in Porto Velho.

    Georeferences of <i>Mansonia</i> spp. monitoring points in Porto Velho. by José Ferreira Saraiva (4911748)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: